nct02637284 bpc-157 status A human trial was registered. The results were submitted. Then they disappeared from public view. In 2015, a Phase I, randomized, placebo-controlled clinical trial (NCT02637284) was launched Croatian scientist Predrag Sikiric has
Description
Zinc Pyrithione: Targeting the Microbial Trigger Zinc pyrithione is most commonly known as the active ingredient in many anti-dandruff shampoos
That single design decision changes everything about how the molecule behaves: ACTH 4-7 itself is cleaved in seconds by brain and plasma peptidases, whereas Semax persists long enough to drive profound transcriptional effects on brain-derived neurotrophic factor and nerve growth factor
The FDA made several important announcements that affected peptide availability
Evidence is preliminary, and it is not an FDA-approved treatment for any medical condition
